SynthesisBMC cardiovascular disorders2016

Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studies.

Manel Pladevall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.